UCB’s growth driver squares up against the competition

UCB’s growth driver squares up against the competition

Submitted by admin on June 11, 2020 - 12:20pm
Source: 
EP Vantage
News Tags: 
UCB Pharma
bimekizumab
psoriasis
clinical trials
Novartis
Cosentyx
Headline: 
UCB’s growth driver squares up against the competition
snippet: 

With data from a head-to-head trial against Cosentyx due soon, UCB’s bimekizumab seeks to enter a crowded psoriasis market.

Do Not Allow Advertisers to Use My Personal information